Matthew Perry’s Friend Says Testosterone Shots Made Him ‘Angry’ Prior To His Death

Friends star Matthew Perry’s sudden death sparked a lot of controversies due to the actor’s drug addiction history, as people believed that he might have relapsed towards the end of his life. Their suspicion became intense when the law enforcement agency ascertained that there was no foul play concerning his death, but they initially refused to reveal his toxicology reports.

Finally, the Los Angeles police department published those reports on December 15, and the outcome is not far-fetched from the rumors flying around. Perry’s demise is now attributed to a dangerous combination of ketamine and various medications detected in his system. Following the recent update, an insider shared compelling insights into the events leading up to Perry’s final days.

A friend of Matthew Perry says he was “angry” and “mean” weeks before his death

The recent toxicology report revealed a stark contrast to the image Perry projected to his friends and colleagues. It showed that the actor had indulged in the use of a variety of substances, evident from his living room, which harbored numerous nicotine vaping products, Viagra, and a hair-loss drug while he stored nicotine lollipops in his refrigerator.

RELATED: Jennifer Aniston Sparks Reaction With First Public Appearance Since Matthew Perry’s Death

A female acquaintance of the late actor also attested to his drug use as she mentioned that Perry had been undergoing testosterone shots in the weeks leading up to his tragic demise, which resulted in a change in his demeanor in terms of anger and hostility.

Autopsy says the actor’s system was loaded with ketamine

Despite Perry undergoing ketamine infusion therapy for depression and anxiety, the last session occurred a week and a half prior to his demise. The autopsy report revealed an unusually high level of ketamine in Perry’s body, which contradicted the expected dosage from the recent infusion.

The report emphasized that the observed ketamine concentration couldn’t have resulted from the therapy, given ketamine’s short half-life of three to four hours.